The largest database of trusted experimental protocols

P8430

Manufactured by Merck Group

The P8430 is a laboratory equipment product from Merck Group. It is designed for general laboratory use. The core function of the P8430 is to provide a precise and reliable tool for laboratory tasks, but a detailed description while maintaining an unbiased and factual approach is not available.

Automatically generated - may contain errors

3 protocols using p8430

1

Cytosol-Membrane Fractionation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytosol/membrane fractionation assay was performed according to a previously described method (Baghirova et al., 2015 (link)). Briefly, HEK 293T cells were harvested by trypsin treatment and washed with ice-cold PBS. Fractionation buffer FA (150 mM NaCl, 50 mM HEPES pH 7.4, 100 μg/ml digitonin (D141, Sigma), and 1 M hexylene glycol) supplemented with 1x protease inhibitor cocktail (P8340, Sigma, 100x stock solution) was added to the harvested cells to release cytosolic proteins. After incubation for 15 min on an end-to-end rotator at 4 ˚C, samples were centrifuged at 2,000 g for 10 min. The resulting supernatant was transferred and marked as cytosolic proteins. Fractionation buffer FB (150 mM NaCl, 50 mM HEPES pH 7.4, 1% (v/v) Nonidet-P40, and 1 M hexylene glycol) supplemented with 1x protease inhibitor cocktail (P8430, Sigma, 100x stock solution) was added to the resulting cell pellets to release membrane proteins. After incubation for 30 min on ice, samples were centrifuged at 7,000 g for 10 min. The resulting supernatant was transferred and marked as membrane proteins. Both cytosolic and membrane fractions were further immunoprecipitated using a FLAG-M2-affinity gel (A2220, Sigma, RRID:AB_10063035) and analyzed by immunoblotting. These experiments were repeated twice.
+ Open protocol
+ Expand
2

Cell Lysis and Fractionation for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibroblasts cultured on elastic surfaces were trypsinized and pelleted prior to lysis. Cell pellets were lysed with RIPA lysis buffer (1% NP-40; 0.5% NaDOC; 0.1% SDS; 50 mM Tris–HCl, pH 7.4; 150 mM NaCl; 10% glycerol; 1 mM EDTA) supplemented with protease inhibitors (Sigma, P8430) and phosphatase inhibitors (10 mM NaF; 1 mM Na3VO4; 1 mM EGTA). Lysates were incubated on ice for 30 min with periodic vortexing; this was followed by brief sonication and centrifugation at 16 000 × g for 15 min at 4 °C. Cleared lysates were then transferred to fresh microcentrifuge tubes for total protein determination by BCA assay (Thermo Scientific, # 23,225). Cytoplasmic and nuclear cell fractionation was achieved using the Pierce NE-PER™ Extraction reagents (Thermo Scientific, #78,833). All samples were kept at –20 °C for short-term use, or –80 °C for long-term storage (Table 1).

siRNA oligo pools

TargetSpeciesAccessionPool (Dharmacon™ Cat#)
Lats1R. norvegicusNM_001134543.2M-080189–01-0005
Lats2R. norvegicusNM_001107267.1M-087043–01-0005
Limd1R. norvegicusNM_001112737.2L-081750–02-0005
SkiR. norvegicusXM_017593893L-099478–02-0005
Wwtr1 (Taz)R. norvegicusNM_001024869.1M-088521–01-0005
Non-targeting poolH. sapiens, M. musculus, R. norvegicusn/aD-001810–10-05
+ Open protocol
+ Expand
3

Western Blot Analysis of ABCA1 and ApoA-I

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver samples were homogenised in lysis buffer (1 % Triton X-100, 0•5 % sodium deoxycholate, 0•1 % SDS, 150 mM-NaCl, 2 mM-EDTA and 50 mM-Tris -HCl, pH 7•5) containing freshly added proteinase inhibitors (P8430; Sigma) and phosphatase inhibitors (P2850 and P5726; Sigma). After centrifugation at 20 000 g for 30 min at 48C, the supernatant was used for Western blotting and the pellet was discarded. Protein extracts were separated on a 4 -15 % SDS PAGE gel and transferred to nitrocellulose membranes (Bio-Rad 162-0113). The membranes were blocked with 5 % skimmed milk, probed with an appropriate primary antibody (anti-ABCA1 antibody ab151685, Abcam and anti-apoA-I rabbit polyclonal antibody (FL-267): sc-30 089), incubated with an appropriate horseradish peroxidase-conjugated secondary antibody (anti-rabbit IgG, Abcam (ab97051)), and then developed with the addition of a substrate. The bands were then quantified.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!